Reliance damages

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results

Retrieved on: 
Tuesday, May 11, 2021

The Company anticipates topline data readout in the third quarter of 2021 for the TMB-001 study.

Key Points: 
  • The Company anticipates topline data readout in the third quarter of 2021 for the TMB-001 study.
  • The Company\'s investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles.
  • Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release.
  • The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.\n'

Reliance Steel & Aluminum Co. Announces Director Succession and Leadership Promotions

Retrieved on: 
Monday, January 18, 2021

Her term as a director also took effect on January 15, 2021, and will expire at Reliances 2021 Annual Meeting of Stockholders.

Key Points: 
  • Her term as a director also took effect on January 15, 2021, and will expire at Reliances 2021 Annual Meeting of Stockholders.
  • "Karla has demonstrated excellent judgment and leadership in each role she has held since joining Reliance in 1992.
  • He has been a director of Reliance since 1992 and was Chairman of the Board from 2007 to 2016.
  • Reliance Steel & Aluminum Co.s press releases and additional information are available on the Companys website at www.rsac.com .